A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...
A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...
A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...
Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...
Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...
Semax, a synthetic analogue of the adrenocorticotropic hormone (ACTH), has been extensively researched for its neuroprotective and neuroregenerative properties. Developed in the late 1980s by Russian ...
New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.
A nasal spray drug can counteract the cognitive decline and brain damage typical of Alzheimer's disease in animal models.